Yanan Xu

1.3k total citations
54 papers, 776 citations indexed

About

Yanan Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yanan Xu has authored 54 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Yanan Xu's work include Cancer-related molecular mechanisms research (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Yanan Xu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Yanan Xu collaborates with scholars based in China and United States. Yanan Xu's co-authors include Houyu Wang, Yao He, Chaoqun Wang, Yong Ma, Zihao Li, Hongchi Jiang, Shounan Lu, Qian Zhang, Bin Song and Zhi Tan and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Nano Letters.

In The Last Decade

Yanan Xu

48 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanan Xu China 18 376 142 100 82 77 54 776
Xiaochen Li China 18 511 1.4× 97 0.7× 97 1.0× 86 1.0× 78 1.0× 49 970
Norshariza Nordin Malaysia 18 420 1.1× 94 0.7× 87 0.9× 96 1.2× 111 1.4× 71 1.2k
Yanling Lin China 18 415 1.1× 110 0.8× 177 1.8× 70 0.9× 58 0.8× 61 1.0k
Yonggang Zhang China 18 329 0.9× 92 0.6× 154 1.5× 81 1.0× 53 0.7× 61 825
Jing Guo China 20 715 1.9× 82 0.6× 97 1.0× 83 1.0× 59 0.8× 76 1.1k
Yingying Liu China 15 574 1.5× 119 0.8× 109 1.1× 56 0.7× 79 1.0× 36 826
Lei Peng China 16 341 0.9× 132 0.9× 62 0.6× 53 0.6× 65 0.8× 40 906
Jingge Zhang China 16 340 0.9× 106 0.7× 119 1.2× 135 1.6× 66 0.9× 54 787

Countries citing papers authored by Yanan Xu

Since Specialization
Citations

This map shows the geographic impact of Yanan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Xu more than expected).

Fields of papers citing papers by Yanan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Xu. The network helps show where Yanan Xu may publish in the future.

Co-authorship network of co-authors of Yanan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Xu. A scholar is included among the top collaborators of Yanan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Xu. Yanan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chaoqun, Shounan Lu, Yanan Xu, et al.. (2025). Arsenic trioxide preconditioning attenuates hepatic ischemia- reperfusion injury in mice: Role of ERK/AKT and autophagy. Chinese Medical Journal. 138(22). 2993–3003.
2.
Wang, Chaoqun, Baolin Qian, Bing Yin, et al.. (2025). GRINA alleviates hepatic ischemia‒reperfusion injury-induced apoptosis and ER-phagy by enhancing HRD1-mediated ATF6 ubiquitination. Journal of Hepatology. 83(1). 131–145. 5 indexed citations
3.
Li, Li, et al.. (2025). TREK-1 and epilepsy: regulating the balance of K+ and the glutamate release in astrocyte-neuron interactions. Behavioral and Brain Functions. 21(1). 27–27.
5.
Lu, Shounan, Yanan Xu, Bing Yin, et al.. (2024). RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma. Experimental & Molecular Medicine. 56(6). 1412–1425. 4 indexed citations
6.
Zhou, Menghua, Shounan Lu, Chaoqun Wang, et al.. (2024). IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway. Cancer Science. 115(3). 777–790. 10 indexed citations
7.
Wang, Chaoqun, Shounan Lu, Yanan Xu, et al.. (2023). RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. Oncogene. 42(24). 2017–2030. 10 indexed citations
8.
Xu, Yanan, Shounan Lu, Chaoqun Wang, et al.. (2023). HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway. Oncogenesis. 12(1). 2–2. 9 indexed citations
9.
Li, Xinglong, Bing Yin, Jingjing Huang, et al.. (2023). Comprehensive analysis of transcriptome‐wide M 6 A methylation for hepatic ischaemia reperfusion injury in mice. Epigenetics. 18(1). 2201716–2201716. 5 indexed citations
10.
Lu, Shounan, Chaoqun Wang, Yanan Xu, et al.. (2022). NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis. Oncogenesis. 11(1). 39–39. 28 indexed citations
11.
Xu, Yanan, Xinglong Li, Bing Yin, et al.. (2022). Integrative analysis of the roles of lncRNAs and mRNAs in ischaemic preconditioning to alleviate liver ischaemia–reperfusion injury in mice. Biochemical and Biophysical Research Communications. 627. 30–38.
12.
Wang, Chaoqun, Zihao Li, Baolei Zhao, et al.. (2021). PGC‐1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production. Oxidative Medicine and Cellular Longevity. 2021(1). 6677955–6677955. 17 indexed citations
13.
Qu, Di, Huihui� Guo, & Yanan Xu. (2021). Effects of Tranilast on Inflammasome and Macrophage Phenotype in a Mouse Model of Myocardial Infarction. Journal of Interferon & Cytokine Research. 41(3). 102–110. 4 indexed citations
14.
Zhou, Menghua, Chaoqun Wang, Shounan Lu, et al.. (2021). Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target. EBioMedicine. 67. 103375–103375. 43 indexed citations
15.
Xu, Yanan, et al.. (2021). Low-grade elevation of palmitate and lipopolysaccharide synergistically induced β-cell damage via inhibition of neutral ceramidase. Molecular and Cellular Endocrinology. 539. 111473–111473. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026